As of 2024-07-27, the Relative Valuation of Biogen Inc (BIIB) is 272.26 USD. This relative valuation is based on P/E multiples. With the latest stock price at 211.17 USD, the upside of Biogen Inc based on Relative Valuation is 28.9%.
The range of the Relative Valuation is 240.16 - 351.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.9x - 43.9x | 36.6x |
| Forward P/E multiples | 31.5x - 37.1x | 33.0x |
| Fair Price | 240.16 - 351.42 | 272.26 |
| Upside | 13.7% - 66.4% | 28.9% |
| Date | P/E |
| 2024-07-26 | 26.36 |
| 2024-07-25 | 28.39 |
| 2024-07-24 | 28.21 |
| 2024-07-23 | 27.99 |
| 2024-07-22 | 28.29 |
| 2024-07-19 | 28.26 |
| 2024-07-18 | 28.11 |
| 2024-07-17 | 28.50 |
| 2024-07-16 | 28.08 |
| 2024-07-15 | 27.65 |
| 2024-07-12 | 28.71 |
| 2024-07-11 | 29.55 |
| 2024-07-10 | 29.05 |
| 2024-07-09 | 28.59 |
| 2024-07-08 | 28.46 |
| 2024-07-05 | 28.16 |
| 2024-07-03 | 28.03 |
| 2024-07-02 | 28.56 |
| 2024-07-01 | 28.93 |
| 2024-06-28 | 28.93 |
| 2024-06-27 | 28.55 |
| 2024-06-26 | 28.01 |
| 2024-06-25 | 27.86 |
| 2024-06-24 | 28.28 |
| 2024-06-21 | 27.96 |
| 2024-06-20 | 28.15 |
| 2024-06-18 | 27.91 |
| 2024-06-17 | 28.26 |
| 2024-06-14 | 28.92 |
| 2024-06-13 | 29.18 |
| 2024-06-12 | 28.78 |
| 2024-06-11 | 28.17 |
| 2024-06-10 | 28.20 |
| 2024-06-07 | 28.14 |
| 2024-06-06 | 28.95 |
| 2024-06-05 | 29.54 |
| 2024-06-04 | 29.22 |
| 2024-06-03 | 28.68 |
| 2024-05-31 | 28.07 |
| 2024-05-30 | 27.47 |
| 2024-05-29 | 26.76 |
| 2024-05-28 | 27.30 |
| 2024-05-24 | 27.18 |
| 2024-05-23 | 27.22 |
| 2024-05-22 | 28.11 |
| 2024-05-21 | 28.42 |
| 2024-05-20 | 28.90 |
| 2024-05-17 | 28.78 |
| 2024-05-16 | 28.71 |
| 2024-05-15 | 29.37 |